Reckitt Benckiser Group plc Class Action: Levi & Korsinsky Reminds Reckitt Benckiser Group plc Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of August 4, 2025 – RBGLY

Core Viewpoint - A class action securities lawsuit has been filed against Reckitt Benckiser Group plc, alleging securities fraud that negatively impacted investors between January 13, 2021, and July 28, 2024 [1][2] Group 1: Allegations and Impact - The lawsuit claims that Reckitt's cow's milk-based formula, Enfamil, increased the risk of preterm infants developing NEC, which was not disclosed [2] - It is alleged that the defendants made materially false and misleading statements regarding the company's business and sales prospects, particularly concerning Enfamil [2] Group 2: Legal Process and Participation - Investors who suffered losses during the specified timeframe have until August 4, 2025, to request appointment as lead plaintiff, although participation in any recovery does not require this [3] - Class members may be entitled to compensation without any out-of-pocket costs or fees [3] Group 3: Firm Background - Levi & Korsinsky has a strong track record in securities litigation, having secured hundreds of millions for shareholders over the past 20 years [4] - The firm has been recognized as one of the top securities litigation firms in the United States for seven consecutive years [4]